Document Type

Presentation

Loading...

Media is loading
 

Publication Date

1-16-2013

Comments

Dr. Michael Scharf joing Thomas Jefferson's Division of Pulmonary and Critical Care Medicine in February 2009 as a Clinical Associate Professor of Medicine. After graduating from New York Medical College, he completed his internal medicine residency at the Montefiore Medical Center in the Bronx, New York and fellowships in pulmonary and critical care medicine at the Hospital of the University of Pennsylvania and Temple University Hospital. After fellowship, he joined the pulmonary medicine staff at the Deborah Heart and Lung Center in Browns Mills, New Jersey, where he served as director of the pulmonary function lab and the library and continuing education committee and founded and directed their pulmonary hypertension program.

At Jefferson, he serves as the Director of the Pulmonary Vascular Disease Program and one full day weekly, evaluates patients for pulmonary hypertension at the Jefferson Heart Institute. His patients receive PAH-specific medicines under his direction, including parenteral and inhaled prostacyclins and oral therapies. His research interests include exercise assessment in PAH, evaluation of sleep disorders in PAH, and right heart dysfunction in sickle cell patients. He is the principal investigator in industry-sponsored various PAH-related trials and registries. Dr. Scharf also evaluates and treats patients with general pulmonary issues and serves as the medical director of the Jefferson University Physician's pulmonary outpatient practice.

Abstract

Objectives:

1. List determinants of the normal pulmonary circulation.

2. Recognize predictors of short-term morbidity after non-cardiac surgery in PAH.

3. Discuss the relative risk of the type of non-cardiac surgery on post-operative outcome in PAH.

Presentation: 54 minutes.

Download Presentation

Share

COinS